X-ray induction of 6-thioguanine-resistant mutants in division arrested, G0/G1 phase Chinese hamster ovary cells.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 4000168)

Published in Mutat Res on July 22, 1985

Authors

J P O'Neill, K B Flint

Articles by these authors

(truncated to the top 100)

Molecular analyses of in vivo hprt mutations in human T-lymphocytes. I. Studies of low frequency 'spontaneous' mutants by Southern blots. Mutagenesis (1987) 2.33

The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res (2000) 2.01

Two forms of biosynthetic acetohydroxy acid synthetase in Salmonella typhimurium. Biochem Biophys Res Commun (1972) 1.94

In vivo somatic mutations in humans: measurement and analysis. Annu Rev Genet (1990) 1.83

Serum mannose-binding lectin deficiency is associated with cryptosporidiosis in young Haitian children. Clin Infect Dis (2006) 1.64

Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat Med (1998) 1.58

Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes. Nature (1985) 1.52

High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination. Cancer Res (1997) 1.48

Temperature-sensitive growth inhibition by valine in Salmonella typhimurium: alteration of one form of acetohydroxy acid synthetase. J Bacteriol (1973) 1.33

Treatment of intertrochanteric fracture of the femur using sliding screw plate fixation. Clin Orthop Relat Res (1982) 1.32

A quantitative assay of mutation induction at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells (CHO/HGPRT system): development and definition of the system. Mutat Res (1977) 1.25

The spectrum of mutations causing HPRT deficiency: an update. Nucleosides Nucleotides Nucleic Acids (2004) 1.14

V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes. Cancer Res (1991) 1.14

DNA sequence analysis of in vivo hprt mutation in human T lymphocytes. Mutagenesis (1990) 1.12

Chemical mutagenesis of mammalian cells can be quantified. Nature (1977) 1.11

Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis (1994) 1.05

Possible role of adenosine cyclic 3':5'-monophosphate phosphodiesterase in the morphological transformation of Chinese hamster ovary cells mediated by N6,O2-dibutyryl adenosine cyclic 3':5"-monophosphate. J Biol Chem (1975) 1.04

Effect of cyclopentaneglycine on metabolism in Salmonella typhimurium. J Bacteriol (1972) 0.98

A quantitative assay of mutation induction at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells (CHO/HGPRT system): utilization with a variety of mutagenic agents. Mutat Res (1977) 0.97

The use of Chinese hamster ovary cells to quantify specific locus mutation and to determine mutagenicity of chemicals. A report of the gene-tox program. Mutat Res (1981) 0.94

Molecular description of three macro-deletions and an Alu-Alu recombination-mediated duplication in the HPRT gene in four patients with Lesch-Nyhan disease. Mutat Res (2001) 0.94

Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutat Res (1994) 0.93

The effect of folate deficiency on the hprt mutational spectrum in Chinese hamster ovary cells treated with monofunctional alkylating agents. Mutat Res (1999) 0.92

Quantitative analyses of radiation- and chemical-induced lethality and mutagenesis in Chinese hamster ovary cells. Radiat Res (1978) 0.91

Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in thirteen Spanish families. Hum Mutat (2000) 0.91

Factors influencing mutation at the hprt locus in T-lymphocytes: studies in normal women and women with benign and malignant breast masses. Environ Mol Mutagen (1992) 0.91

Molecular analyses of in vivo hprt mutations in human T-lymphocytes. III. Longitudinal study of hprt gene structural alterations and T-cell clonal origins. Mutat Res (1989) 0.91

In vivo ionizing irradiations produce deletions in the hprt gene of human T-lymphocytes. Mutat Res (1991) 0.90

Genotoxic markers among butadiene polymer workers in China. Carcinogenesis (2000) 0.90

Correlation between changes in intracellular level of cyclic AMP, activation of cyclic AMP-dependent protein kinase, and the morphology of Chinese hamster ovary cells in culture. Arch Biochem Biophys (1977) 0.90

Phenotypic expression time of mutagen-induced 6-thioguanine resistance in Chinese hamster ovary cells (CHO/HGPRT system). Mutat Res (1979) 0.90

Molecular analyses of in vivo hypoxanthine-guanine phosphoribosyltransferase mutations in human T-lymphocytes: II. Demonstration of a clonal amplification of hprt mutant T-lymphocytes in vivo. Environ Mol Mutagen (1988) 0.89

Germinal HPRT splice donor site mutation results in multiple RNA splicing products in T-lymphocyte cultures. Somat Cell Mol Genet (1996) 0.89

Fine structure mapping of the hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene region of the human X chromosome (Xq26). Am J Hum Genet (1991) 0.89

Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutat Res (1993) 0.89

Hudrolysis of butyryl derivatives of adenosine cyclic 3':5'-monophosphate by Chinese hamster ovary cell extracts and characterization fo the products. J Biol Chem (1975) 0.89

An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets. Mutat Res (1994) 0.88

Induction and expression of mutations in mammalian cells in the absence of DNA synthesis and cell division. Mutat Res (1982) 0.87

HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts. Carcinogenesis (1993) 0.87

Molecular analysis of in vivo hprt mutations in human T lymphocytes. V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT) Mutagenesis (1990) 0.87

Genotoxicity of 3'-azido-3'-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT. Mutat Res (1999) 0.86

Mutagenicity monitoring in humans by autoradiographic assay for mutant T lymphocytes. Mutat Res (1988) 0.86

The effect of folate deficiency on the cytotoxic and mutagenic responses to ethyl methanesulfonate in human lymphoblastoid cell lines that differ in p53 status. Mutat Res (2001) 0.86

Markers for carcinogenicity among butadiene-polymer workers in China. Chem Biol Interact (2001) 0.86

HPRT mutations in vivo in human CD 34+ hematopoietic stem cells. Mutat Res (1999) 0.85

V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans. Mutat Res (1992) 0.85

hprt mutation frequency among workers exposed to 1,3-butadiene in China. Toxicology (1996) 0.85

Quantification and analysis of reverse mutations at the hgprt locus in Chinese hamster ovary cells. Mutat Res (1982) 0.84

Enumeration of 6-thioguanine-resistant T-lymphocytes in the peripheral blood of nonhuman primates (cynomolgus monkeys). Environ Mol Mutagen (1991) 0.84

Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mutat Res (1995) 0.84

Increased frequency of specific genomic deletions resulting from in vitro malathion exposure. Cancer Res (1996) 0.83

Sensitivity of somatic mutations in human umbilical cord blood to maternal environments. Environ Mol Mutagen (1995) 0.82

A guide for the performance of the Chinese hamster ovary cell/hypoxanthine-guanine phosphoribosyl transferase gene mutation assay. Mutat Res (1987) 0.82

Fluctuation analyses of spontaneous mutations to 6-thioguanine resistance in Chinese hamster ovary cells in culture. Mutat Res (1981) 0.82

Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymphocytes. Mutat Res (1986) 0.82

Development of long PCR techniques to analyze deletion mutations of the human hprt gene. Mutat Res (1998) 0.82

Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions. Cancer Res (2001) 0.81

Genetic instability in human T-lymphocytes. Mutat Res (1998) 0.81

Factors influencing mutation at the hprt locus in T-lymphocytes: women treated for breast cancer. Cancer Res (1991) 0.81

Phenotypic expression time of mutagen-induced 6-thioguanine resistance in Chinese hamster ovary cells (CHO/HGPRT system): expression in division-arrested cell cultures. Environ Mutagen (1982) 0.81

Mutagenicity, cytotoxicity, and DNA binding of platinum(II)-chloroammines in Chinese hamster ovary cells. Cancer Res (1980) 0.81

Hypoxanthine-guanine phosphoribosyltransferase deficiency: biochemical and molecular findings in six Argentine patients. Nucleosides Nucleotides Nucleic Acids (2007) 0.81

Molecular analyses of a Lesch-Nyhan syndrome mutation (hprtMontreal) by use of T-lymphocyte cultures. Hum Genet (1990) 0.81

Effect of folate deficiency on mutations at the hprt locus in Chinese hamster ovary cells exposed to monofunctional alkylating agents. Cancer Res (1997) 0.80

In vivo mutations in human blood cells: biomarkers for molecular epidemiology. Environ Health Perspect (1993) 0.80

The induction of specific-locus mutations and sister-chromatid exchanges by 5-bromo- and 5-chloro-deoxyuridine. Mutat Res (1982) 0.80

SCE induction is proportional to substitution in DNA for thymidine by CldU and BrdU. Mutat Res (1983) 0.80

Quantitative analysis of cytotoxicity and mutagenicity of benzo[a]pyrene in mammalian cells (CHO/HGPRT system). Chem Biol Interact (1981) 0.79

Contribution of foods to trans unsaturated fatty acid intake in a group of Irish adults. J Hum Nutr Diet (2005) 0.79

Future research directions for evaluating human genetic and cancer risk from environmental exposures. Environ Health Perspect (1996) 0.79

Cytotoxicity and mutagenicity of dimethylnitrosamine in mammalian cells (CHO/HGPRT system); enhancement by calcium phosphate. Environ Mutagen (1982) 0.79

Ongoing challenges in the treatment of adenoid cystic carcinoma of the head and neck. Ir J Med Sci (2015) 0.79

Mutagenicity of heterocyclic nitrogen mustards (ICR compounds) in cultured mammalian cells. Cancer Res (1978) 0.79

The cell cycle specificity of the morphological conversion of chinese hamster ovary cells by N6, O2'-dibutyryl cyclic adenosine 3',5'-phosphate. Exp Cell Res (1976) 0.79

Sister-chromatid exchanges and gene mutations are induced by the replication of 5-bromo- and 5-chloro-deoxyuridine substituted DNA. Mutat Res (1983) 0.78

Radiation quality affects the efficiency of induction and the molecular spectrum of HPRT mutations in human T cells. Radiat Res (1997) 0.78

Molecular bases of hprt mutations in malathion-treated human T-lymphocytes. Mutat Res (1998) 0.78

Oncogenic impact of human papilloma virus in head and neck cancer. J Laryngol Otol (2010) 0.78

hprt mutations in vivo in human T-lymphocytes: frequencies, spectra and clonality. Prog Clin Biol Res (1990) 0.78

Nutritional folate deficiency augments the in vivo mutagenic and lymphocytotoxic activities of alkylating agents. Environ Mol Mutagen (1998) 0.78

Studies of DNA alterations in in vivo somatic cell mutations in humans. Basic Life Sci (1990) 0.78

Induction of chromosome aberrations and specific locus mutation but not sister chromatid exchanges in Chinese hamster ovary cells by neocarzinostatin. Teratog Carcinog Mutagen (1984) 0.77

Cytotoxicity and mutagenicity of the fungicides captan and folpet in cultured mammalian cells CHO/HGPRT system). Environ Mutagen (1981) 0.77

Cytotoxicity and mutagenicity of alkylating agents in cultured mammalian cells (CHO/HGPRT system): mutagen treatment in the presence or absence of serum. Mutat Res (1979) 0.77

Mutagenicity of alkaline constituents of a coal-liquified crude oil in mammalian cells. Mutat Res (1980) 0.77

Analysis of human HPRT deletion mutations with X-linked probes and pulsed field gel electrophoresis. Environ Mol Mutagen (1991) 0.77

Somatic cell gene mutations in humans: biomarkers for genotoxicity. Environ Health Perspect (1993) 0.76

Nontargeted stable integration of recombinant adeno-associated virus into human leukemia and lymphoma cell lines as evaluated by fluorescence in situ hybridization. Hum Gene Ther (1999) 0.76

Elevated HPRT mutation frequencies in aflatoxin-exposed residents of daxin, Qidong county, People's Republic of China. Carcinogenesis (1999) 0.76

Mutagenicity and cytotoxicity of nineteen heterocyclic mustards (ICR compounds) in cultured mammalian cells. Cancer Res (1979) 0.76

Vascular corrosion replicas of chemo-baroreceptors in fish: the carotid labyrinth in Ictaluridae and Clariidae. Cell Tissue Res (1981) 0.76

hprt mutant frequencies, nonpulmonary malignancies, and domestic radon exposure: "postmortem" analysis of an interesting hypothesis. Environ Mol Mutagen (2001) 0.75

Quantification and molecular characterization of hprt mutants of human T-lymphocytes. Environ Health Perspect (1993) 0.75

Response to Hanna Re: The diagnosis of infectious mononucleosis by Lennon et al. in a previous issue. Clin Otolaryngol (2012) 0.75

Growth arrest of Chinese hamster ovary cells in serum-free medium: changes in cell morphology and the intracellular and prostaglandin-induced levels of cyclic AMP. J Cyclic Nucleotide Res (1978) 0.75

Molecular characterization of somatic gene mutations arising in vivo in humans. Prog Clin Biol Res (1986) 0.75

Electronics and automation: do you need them? J Biol Photogr Assoc (1978) 0.75

Mutations in the hypoxanthine-guanine phosphoribosyltransferase gene in Spanish HPRT deficient families. Adv Exp Med Biol (2000) 0.75

101 ways to make copy and title slides... some of them good! J Biol Photogr Assoc (1978) 0.75

Sclerosing peritonitis after practolol administration. Med J Aust (1977) 0.75